Compare IAF & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IAF | MBOT |
|---|---|---|
| Founded | 1985 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.4M | 135.7M |
| IPO Year | N/A | N/A |
| Metric | IAF | MBOT |
|---|---|---|
| Price | $13.96 | $1.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 90.4K | ★ 1.1M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 11.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.60 | $1.25 |
| 52 Week High | $4.59 | $4.67 |
| Indicator | IAF | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 80.13 | 41.11 |
| Support Level | $13.11 | $1.96 |
| Resistance Level | $13.31 | $2.21 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 99.99 | 22.22 |
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.